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Saliva Cotinine Levels in Smokers and Nonsmokers
Jean-Francois Etter,1 Trinh Vu Due,2 and Thomas V. Perneger1
The authors collected by mail self-reported data on smoking habits and saliva samples that were analyzed
for cotinine concentration in 222 smokers and 97 nonsmokers. Participants were members of the University of
Geneva (Switzerland) in 1995. The 207 cigarette-only smokers smoked on average 10.7 cigarettes/day and had
a median concentration of cotinine of 113 ng/ml.The cotinine concentration was moderately associated with the
number of cigarettes smoked per day (+14 ng/ml per additional cigarette, p < 0.001, Ff = 0.45) and was 54 ng/ml
higher in men than in women after adjustment for cigarettes per day and for the Fagerstrom Test for Nicotine
Dependence. The cotinine level was not associated with the nicotine yield of cigarettes (r= 0.08). In nonsmokers,
the median concentration of cotinine was 2.4 ng/ml. The cotinine concentration was 1.5 times higher in
nonsmokers whose close friends/spouses were smokers than in nonsmokers whose close friends/spouses were
nonsmokers (p = 0.05). A cutoff of 7 ng/ml of cotinine distinguished smokers from nonsmokers with a sensitivity
of 92.3% and a specificity of 89.7%; a cutoff of 13 ng/ml provided equally satisfactory results (sensitivity, 86.5%;
specificity, 95.9%). This study provides evidence for the construct validity of both questionnaires and saliva
cotinine for the assessment of active and passive exposure to tobacco smoke. Am J Epidemiol
2000;151:251-8.
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Precise estimation of exposure to tobacco smoke is a
concern for epidemiologic studies. The self-reported
number of cigarettes smoked per day may be inaccurate
because of digit bias, over- or underreporting, variability
in the amount of smoke inhaled from a cigarette, and so
on. Assessment of passive exposure to tobacco smoke is
even more problematic (1, 2). An indirect measure of
recent exposure to cigarette smoke is the concentration
of cotinine in the blood, urine, or saliva (3-5). Cotinine
is the principal metabolite of nicotine and has a half-life
of about 17 hours (3). The use of cotinine in epidemio-
logic studies is limited by the cost and difficulty of col-
lecting body fluid samples in large numbers of individu-
als. However, saliva samples can be collected by mail
and analyzed for cotinine concentration (6-11).
The objectives of this study were to evaluate the
relation between saliva cotinine concentration and
self-reported active and passive exposure to tobacco
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smoke, to identify factors associated with saliva coti-
nine levels in smokers, and to determine an optimal
cutoff for the cotinine concentration to distinguish
smokers from nonsmokers.
MATERIALS AND METHODS
Study setting and population
The study population included students, faculty, and
staff of the University of Geneva (Switzerland). We
conducted a mail survey in a random sample of 3,000
university members to evaluate a smoking prevention
intervention (9, 12). The initial mailing was sent to
potential participants in November 1995 and 2,237 per-
sons (75 percent) responded, after up to four reminder
mailings. A random subsample of 1,500 persons
received a saliva vial in the first mailing and were asked
to return a sample of saliva. Requests for saliva samples
were discontinued in reminder mailings, because our
resources allowed laboratory analysis of only a limited
number of samples. Saliva was collected in a plastic vial
containing a sterile dental cotton roll (Salivette;
Sarstedt, Niimbrecht, Germany). Respondents were
asked to chew the cotton roll for 1 minute, at least one-
half hour after eating or drinking, and to replace it in the
tube without touching it. Upon receipt, saliva samples
were frozen at -20°C.
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We received 845 saliva samples (56 percent of
1,500) on average 15 days after the initial mailing. A
subsample of 325 vials were subjected to laboratory
analysis, including all vials of current cigarette smok-
ers (n = 227), a random sample of 50 vials of non-
smokers who reported exposure to environmental
tobacco smoke, and a random sample of 48 vials of
nonsmokers who reported no passive exposure. The
concentration of saliva cotinine could be measured in
319 samples (98.2 percent); six vials contained no
saliva after centrifugation.
Saliva cotinine was measured by capillary gas chro-
matography and nitrogen selective detection (13). The
method had a between-run variation of about 5 percent
and a detection limit of 0.1 ng/ml of saliva.
Questionnaire content
Questions covered smoking history, stages of
change for smoking (14), age, sex, and, for smokers
only, the number of cigarettes smoked per day, pipe or
cigar smoking, age at initiation of daily smoking, num-
ber of years as a regular smoker, the Fagerstrom Test
for Nicotine Dependence (15, 16), attempts to quit
smoking in the past 12 months, and perceived diffi-
culty to quit smoking, assessed by the following ques-
tion: "For you, quitting smoking would be: Very easy,
Easy, Difficult, Very difficult." Smokers were asked to
look at their cigarette pack and report the nicotine
yield written on the pack (in Switzerland in 1995,
nicotine and tar yields were written on all cigarette
packs).
Exposure to environmental tobacco smoke was
assessed by the following questions: "Who is currently
a smoker, among people around you?: Your best friend
(Yes/No), Most of your friends (Yes/No), Your hus-
band or wife or boyfriend or girlfriend (if you have
one) (Yes/No)"; "Do you live with someone who
smokes? (Yes/No)"; and "In university buildings, are
you exposed to other people's tobacco smoke? (Never
to Very often, five levels)."
Analysis plan
First, we assessed associations between cigarette
smoking and saliva cotinine concentrations among the
207 smokers who smoked only cigarettes (pipe and
cigar smokers were excluded to improve the homo-
geneity of exposure assessment).
Second, we assessed associations between saliva
cotinine concentrations and self-reported passive
exposure to tobacco smoke. This analysis concerned
the 97 nonsmokers whose cotinine data were available.
Third, we identified a cutoff level of saliva cotinine
that best distinguished smokers from nonsmokers.
This analysis was conducted in 319 persons: 222
smokers who smoked only cigarettes (n = 207), both
cigarettes and pipe or cigars (n = 14), or only pipe and
cigars (n = 1); and the 97 nonsmokers. Using the self-
report of smoking as the gold standard, we determined
the level of cotinine that maximized the sum of sensi-
tivity and specificity.
Statistical methods
We used t tests to compare means of continuous
variables and chi-square tests to compare proportions.
In nonsmokers, because of one high outlier, we chose
to compare median cotinine values rather than means,
and we used the Mann-Whitney U test for significance
tests. Exploratory analyses of associations between
continuous variables relied on scatter plots and non-
parametric Lowess regression lines (17). A receiver
operating characteristic curve was used to assess the
ability of the saliva cotinine test to detect self-reported
smoking status. Fisher's z transformation was used to
compute 95 percent confidence intervals for Pearson's
correlation coefficients.
RESULTS
Predictors of cotinine concentration in cigarette
smokers
The 207 cigarette-only smokers in this analysis
were on average 28 years old (range, 19-61 years),
43 percent were men, 85 percent were university stu-
dents, and they had received 17 years of education on
average. These participants smoked on average 10.7
cigarettes per day, and their score on the Fagerstrom
Test for Nicotine Dependence averaged 1.7. They
had begun to smoke daily when they were 18 years
old and had been daily smokers for 9 years. All but
three smokers had detectable levels of saliva coti-
nine. In smokers, the cotinine concentrations ranged
from 0 to 838 ng/ml (mean, 166 ng/ml; standard
deviation, 170 ng/ml; quartiles: 30, 113, and 264
ng/ml).
The association between the number of cigarettes
smoked per day and the saliva cotinine level was
almost linear (figure 1). Each additional cigarette
smoked per day was associated with an increase of
14 ng/ml in saliva cotinine (Pearson's correlation:
r - 0.67; 95 percent confidence interval (CI): 0.59,
0.74). This correlation was somewhat stronger
among women (r = 0.75; 95 percent CI: 0.66,
0.82) than among men (/• = 0.61; 95 percent CI:
0.46, 0.73). The cotinine concentration was higher
in men than in women, particularly for smokers of
>5 cigarettes per day (figure 1). There were consid-
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FIGURE 1. Association between the concentration of saliva cotinine and the number of dgarettes smoked per day, in men (dashed line, square
symbols), women (dotted line, round symbols), and smokers of both sexes (solid line) who smoked only dgarettes (no pipes or dgars), Geneva,
Switzerland, 1995.
erable variations in the saliva cotinine concentra-
tions for similar numbers of cigarettes smoked. For
instance, among 30 persons who smoked 20 ciga-
rettes per day, the cotinine concentrations ranged
from 55 to 684 ng/ml (mean, 335 ng/ml; standard
deviation, 164 ng/ml). Scores on the Fagerstrom
test were linearly associated with the cotinine con-
centration (correlation, 0.70; 95 percent CI: 0.62,
0.77) (figure 2).
The self-reported nicotine yield of cigarettes was not
associated with saliva cotinine levels (correlation,
0.08; p = 0.3) (table 1). Men smoked cigarettes with a
higher nicotine yield (0.65 mg) than did women (0.54
mg, p — 0.005), but nicotine yield was unrelated to
saliva cotinine in both men and women.
Age was slightly associated with the cotinine con-
centration, but this association weakened after adjust-
ment for the number of cigarettes per day (table 1).
There was no association between saliva cotinine and
age at initiation of daily smoking, but saliva cotinine
was significantly associated with duration of daily
smoking, even after adjustment for the number of cig-
arettes per day (table 1).
After adjustment for the number of cigarettes
smoked per day, the saliva cotinine concentration was
46 ng/ml higher in smokers in the contemplation stage
than in precontemplators (p — 0.04) and 96 ng/ml
higher in the contemplation than in the preparation
stage of change (p — 0.02).
The saliva cotinine concentration was lower in
smokers who attempted to quit smoking in the previ-
ous year than in those who did not, but this association
disappeared after adjustment for the number of ciga-
rettes smoked per day (table 1).
Among 175 smokers who did not exclude that they
might quit smoking, the perceived difficulty to quit
smoking was strongly associated with the cotinine
concentration. This association remained statistically
significant after adjustment for the number of ciga-
rettes smoked per day (table 1).
In multivariate linear regression analysis, only the
number of cigarettes per day, the Fagerstrom test
score, and sex were independently associated with
saliva cotinine concentrations (table 1). These three
predictors explained 54 percent of the variance in
saliva cotinine concentrations.
Am J Epidemiol Vol. 151, No. 3, 2000
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RGURE 2. Scores on the FagerstrOm Test for Nicotine Dependence and the concentration of saliva cotinine in current smokers who smoked
only cigarettes (no pipes or cigars), Geneva, Switzerland, 1995.
Cotinine concentrations In nonsmokers
The 97 nonsmokers included in this analysis were on
average 28 years old, 34 percent were men, and 79 per-
cent were university students. All but two nonsmokers
had detectable levels of cotinine. The cotinine concen-
trations ranged from 0 to 46 ng/ml, with one outlier at
236 ng/ml (mean, 6.3 ng/ml; median, 2.4 ng/ml; stan-
dard deviation, 24.2 ng/ml). The median concentrations
of saliva cotinine were similar in those who never
TABLE 1. Predictors of concentration of saliva cotinine, In cigarette-only smokers, Geneva,
Switzerland, 1995t
Cigarettes/day (per cigarette)
Sex (men = 1, women = 0)
Fagerstrom Test for Nicotine Dependence (per point on a 0-10
scale)
Age (per year)
Nicotine yield of cigarettes (per mg)
No. of vears as a smoker
Untvarfate
14»«*
86***
6 1 * * *
3*
47 (NS)
4 * *
Cotinine (ng/ml)
Adjusted for
cigarettes/day
56***
39***
2 (NS)*
8(NS)
3*
Multfvartate
6***
54***
39***
Attempted to quit smoking in previous year (made a quit
attempt = 1, no quit attempt = 0) -68** -12 (NS)
Perceived difficulty to quit smoking (per point on a four-point
Ukert scale, among 175 smokers who did not exclude
quitting smoking) 101*** 33*
Stage of change
Precontemplation (reference)
Contemplation 89** 46*
Preparation -72 (NS) -50 (NS)
• p £ 0.05, •* p <> 0.01, • • • p <. 0.001.
t Regression coefficients from linear models indicate the change in saliva cotinine concentration (in ng/ml) per
unit increase in predictors.
X NS, not statistically significant.
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smoked (2.4 ng/ml) and in former smokers (2.8 ng/ml,
p = 0.87), but former smokers in the action stage of
change (median, 9.5 ng/ml) had higher levels of coti-
nine than did former smokers in the maintenance stage
(median, 2.2 ng/ml; p = 0.02). In nonsmokers, the
median saliva cotinine concentration was similar in
men (3.0 ng/ml) and in women (2.4 ng/ml, p = 0.13)
and was not associated with age.
The saliva cotinine concentration was approxi-
mately 1.5 times higher in nonsmokers whose friends
or relatives smoked than in nonsmokers whose
friends/relatives did not smoke (table 2). Living with a
smoker did not predict higher saliva cotinine and nei-
TABLE 2. Concentration of saliva cotinine In nonsmokers
and indicators of exposure to environmental tobacco smoke,
Geneva, Switzerland, 1995
SaHva cotinine,
median (ng/ml)
YBS No
P
value*
Among people around you,
who is currently a smoker?
Your best friend 3.5 2.4 0.42
Most of your friends 3.7 2.4 <0.001
If you have one, your husband/
wife/boyfriend/girlfriend 3.6 2.4 0.05
Do you live with someone who
smokes? 2.4 2.8 0.48
* p value based on the Mann-Whitney Utest.
ther did self-reported exposure to tobacco smoke in
university buildings.
Optimal cutoff to separate smokers and non-
smokers
The distributions of saliva cotinine in smokers and
nonsmokers overlapped (figure 3). The sum of sensi-
tivity and specificity did not change much for cutoff
values between 7 ng/ml (sensitivity, 0.92; specificity,
0.90) and 13 ng/ml (sensitivity, 0.87; specificity, 0.96),
and the area under the receiver operating characteristic
curve was 0.95. Similar cutoff levels were obtained in
men and women (not shown). When the cotinine test
was used to detect smokers of five cigarettes/pipes/
cigars per day (vs. nonsmokers), the sum of sensitivity
and specificity did not change much for cutoff values
between 8 ng/ml (sensitivity, 0.98; specificity, 0.90)
and 40 ng/ml (sensitivity, 0.89; specificity, 0.98), and
the area under the receiver operating characteristic
curve was 0.98.
DISCUSSION
In this study, questionnaires and cotinine data pro-
vided very consistent information about exposure to
tobacco smoke. Three variables independently pre-
dicted saliva cotinine concentrations in current smok-
ers: the number of cigarettes smoked per day, addic-
tion level (Fagerstrom test), and sex.
0.3 2 5 12.5 32 80 200 500
S a l i v a c o t i n i n e ( l o g s c a l e )
FIGURE 3. Saliva cotinine (ng/ml) in smokers (black bars) and nonsmokers (white bars), Geneva, Switzerland, 1995.
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Saliva cotinlne in current smokers
The saliva cotinine concentration was more strongly
correlated with the number of cigarettes per day in our
study (r = 0.67) than in published studies (r =
0.27-0.64) (18-21). This difference may have been
caused by the peculiarities of our study population or
by the use of a more precise measurement of cotinine.
Nevertheless, 55 percent of the variance of cotinine
was explained by factors other than the number of cig-
arettes smoked. This result underlines the necessity of
developing more precise self-reported measures of
intake of cigarette smoke, particularly if researchers
want to quantify the amount of smoke inhaled and not
merely to dichotomize individuals as smokers or non-
smokers.
More precise measurement of cotinine may also
explain why saliva cotinine was more strongly corre-
lated with the Fagerstrom score in our study (r = 0.70)
than in previous studies (r = 0.33 and 0.39) (18, 22).
The significant correlation between a dependence
score and cotinine levels after adjustment for the num-
ber of cigarettes smoked is consistent with (but does
not prove) a causal chain among drug intake (ciga-
rettes smoked), internal concentration of drug (coti-
nine levels), and addiction to drug (Fagerstrom score).
Men usually smoke more cigarettes than do women
and have higher cotinine levels (23-25). Our study
shows that the sex difference in cotinine concentra-
tions is not explained only by a greater number of cig-
arettes smoked, a higher level of nicotine dependence,
or a higher nicotine yield of cigarettes smoked by men.
Higher levels of cotinine in men after adjustment for
cigarettes smoked can be due to sex differences in the
metabolism of nicotine (25, 26), sex-specific bias in
serf-reported smoking habits, or a different way of
smoking cigarettes (rate and depth of inhalation,
unsmoked butt length, and so on).
After adjusting for the number of cigarettes per day,
we found no association between age and cotinine lev-
els. This result contradicts reports that older smokers
have higher cotinine levels than do younger smokers
(21). This discrepancy may be explained by either the
specific smoking patterns of the highly educated older
smokers in our sample or the fact that few older smok-
ers were included in the study.
The absence of association between the self-
reported nicotine yield of cigarettes and the cotinine
concentration confirms that the nicotine yield of ciga-
rettes is not a valid indicator of nicotine intake (27).
Smokers may adjust their blood level of nicotine to
their needs, regardless of the nicotine yield of the cig-
arettes they smoke (28, 29). However, a weak associa-
tion between nicotine yield and saliva cotinine may
have been obscured by imprecise self-report. Several
studies suggest that the smokers' knowledge and
understanding of the tar content of their cigarettes are
inaccurate (30-33), but equivalent data on the associa-
tions between self-reported nicotine yields and the val-
ues printed on cigarette packs are not available.
Saliva cotinine and passive smoking
We found concentrations of saliva cotinine in non-
smokers that were similar to those of previous studies
(3, 34). The saliva cotinine concentration of nonsmok-
ers was influenced by the smoking status of their close
friends or spouses, which justifies the use of the part-
ner's smoking status as an indicator of environmental
tobacco smoke exposure in epidemiologic studies (3,
34-37). On the other hand, we did not replicate the
finding of higher cotinine levels in nonsmokers who
live with smokers (36-38).
Several factors may have weakened the associations
between self-reported exposure to environmental
tobacco smoke and the saliva cotinine concentration.
First, the cotinine concentration reflects exposure to
tobacco smoke in the last few days, whereas the ques-
tionnaire did not specify a time limit. Second,
interindividual differences in nicotine and cotinine
metabolism may have obscured a weak association (3).
Third, the association may have been diluted by a low
reliability of the questionnaire used to assess exposure
to environmental tobacco smoke.
Identification of a cutoff to separate smokers and
nonsmokers
In this study, the level of cotinine concentration that
best divided smokers and nonsmokers (7-13 ng/ml)
was somewhat lower than those in most published
studies, in which cutoffs ranged between 10 and 44
ng/ml (4, 34, 39, 40), or even 100 ng/ml (34). The
lower cutoff in our study may have been due to dif-
ferent internal laboratory standards. Alternatively, the
sensitivity and specificity of the cotinine test may
have been subject to spectrum bias, if the characteris-
tics of smokers and nonsmokers differed between our
study and other studies. In our study, the fact that most
smokers were moderate smokers may have reduced
sensitivity, and low exposure to environmental
tobacco smoke in nonsmokers may have increased
specificity for any given cutoff value. Both conditions
would push the cutoff value lower compared with
other populations.
In this study, a detailed analysis of questionnaire
data showed that all self-reported smokers whose coti-
nine values were below the cutoff of 7-13 ng/ml
smoked few cigarettes or few pipes or cigars.
Conversely, all self-reported nonsmokers whose coti-
Am J Epidemiol Vol. 151, No. 3, 2000
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nine was above this cutoff reported a passive exposure
to tobacco smoke. Only two participants who classi-
fied themselves as nonsmokers had cotinine levels typ-
ical of active smokers, but questionnaire data indicated
that they were in fact occasional smokers. These
results, together with the high area under the receiver
operating characteristic curve, indicate that question-
naire data and cotinine measurements provided very
consistent information about exposure to tobacco
smoke. In addition, we have shown previously that
requesting a saliva sample did not affect the sincerity
of answers on smoking status and on the number of
cigarettes smoked per day, but it decreased response
rates (8). Thus, at least in populations of educated
moderate adult smokers, verification of the partici-
pants' smoking status with biochemical tests may not
be necessary. Rather, researchers should aim at
improving the validity of questionnaires, in particular
by assessing occasional or irregular use of tobacco
(41-43).
Limitations of the study
This study has several limitations. First, we did not
collect data on the use of nicotine replacement prod-
ucts. In Switzerland in 1995, these products were sold
under medical prescription to prevent relapse in
exsmokers. Thus, if some participants used these
products, this would have artificially increased coti-
nine levels in exsmokers. This may have been the case
of one former smoker who had very high cotinine lev-
els in our survey. Second, we had incomplete data on
exposure to environmental tobacco smoke, as our
questions focused on university buildings. Third, coti-
nine is not a specific marker of tobacco use, since
nicotine is found in tea, tomatoes, eggplants, potatoes,
and so on (44). However, at the usual levels of food
consumption, nicotine intake in food is trivial com-
pared with even moderate exposure to environmental
tobacco smoke (3). Finally, this study was conducted
in young and educated participants, most of whom
were university students and moderate smokers. The
results may not apply to older and less educated per-
sons or to heavier smokers.
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